Treatment of subarachnoid hemorrhage: the ability of epsilon aminocaproic acid to cross the blood brain barrier and reduce the spinal fluid fibrinolytic activity.
作者信息
Levy B J, Silver D
出版信息
Surg Forum. 1968;19:413-4.
PMID:5718686
Abstract
摘要
相似文献
1
2
Fibrinolytic activity of the spinal fluid and meninges.脑脊液和脑膜的纤溶活性。
Surg Forum. 1966;17:425-7.
3
[The effect of epsilon-aminocaproic acid on hemocoagulation in subarachnoid hemorrhage. Preliminary study].
Cesk Neurol Neurochir. 1986 Sep;49(5):320-4.
4
Nursing problems of patients undergoing aminocaproic acid treatment for subarachnoid hemorrhage due to aneurysm.因动脉瘤导致蛛网膜下腔出血而接受氨甲环酸治疗的患者的护理问题。
J Neurosurg Nurs. 1979 Sep;11(3):160-5.
5
Plasminogen depletion during administration of epsilon-aminocarproic acid.在给予ε-氨基己酸期间纤溶酶原耗竭。
Thromb Diath Haemorrh. 1973 Jun 28;29(3):598-602.
6
[Current status of intrathecal antifibrinolytic therapy with p-aminomethylbenzoic acid (PAMBA) in subarachnoid hemorrhages].
Psychiatr Neurol Med Psychol (Leipz). 1985 Dec;37(12):686-9.
7
[Fibrinolytic late hemorrhage following prostatectomy. Successful management using Cohn's fraction in combination with epsilon-aminocaproic acid].
Zentralbl Chir. 1968 Apr 13;93(15):546-9.
8
[Antifibrinolytic therapy of subarachnoid hemorrhage. Permeation of oral paraaminomethylbenzoic acid in the cerebrospinal fluid].
Psychiatr Neurol Med Psychol (Leipz). 1980 Apr;32(4):214-9.
9
10
[The use of epsilon-aminocaproic acid in urology].[ε-氨基己酸在泌尿外科的应用]
Z Urol Nephrol. 1965 Oct-Nov;58(10):717-25.
引用本文的文献
1
Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage.抗纤维蛋白溶解疗法预防蛛网膜下腔出血后早期再出血
Neurocrit Care. 2008;8(3):418-26. doi: 10.1007/s12028-008-9088-5.
2
Monitoring fibrinolytic activity in the cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: a guide to the risk of rebleeding?监测动脉瘤性蛛网膜下腔出血后脑脊液中的纤溶活性：再出血风险的指南？
J Neurol Neurosurg Psychiatry. 1980 Feb;43(2):175-81. doi: 10.1136/jnnp.43.2.175.
3
Determination of tranexamic acid (AMCA) and fibrin/fibrinogen degradation products in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage.动脉瘤性蛛网膜下腔出血后脑脊液中氨甲环酸（AMCA）及纤维蛋白/纤维蛋白原降解产物的测定
Acta Neurochir (Wien). 1981;58(1-2):1-13. doi: 10.1007/BF01401679.
4
Anti-fibrinolytic treatment in the pre-operative management of subarachnoid haemorrhage caused by ruptured intracranial aneurysm.颅内动脉瘤破裂所致蛛网膜下腔出血术前管理中的抗纤维蛋白溶解治疗
J Neurol Neurosurg Psychiatry. 1981 Mar;44(3):220-6. doi: 10.1136/jnnp.44.3.220.
5
Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA).动脉瘤性蛛网膜下腔出血后血液和脑脊液中的凝血与纤溶：氨甲环酸（AMCA）的作用
Acta Neurochir (Wien). 1981;56(1-2):25-38. doi: 10.1007/BF01400969.
6
Antifibrinolytic treatment in subarachnoid haemorrhage: present state.蛛网膜下腔出血的抗纤溶治疗：现状
Acta Neurochir (Wien). 1982;63(1-4):233-44. doi: 10.1007/BF01728877.
Zotero 插件